Generics - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

1051 to 1075 of 1525 results

iBio uses iBioLaunch technology to produce functional MAb copy of Synagis

11-04-2012

US biotech firm iBio (NYSE AMEX: IBIO) says that its proprietary iBioLaunch technology for the production…

AstraZenecaBiotechnologyiBIOMedImmunePalivizumabResearchRespiratory and PulmonarySynagis

Recommendations on universal health care coverage in India

10-04-2012

India Health Progress has released the analysis presented by Dileep Malvankar, Dean of Public Health,…

Asia-PacificFinancialGenericsHealthcarePharmaceuticalPricing

Senior exec changes actual or sought at Johnson & Johnson, AstraZeneca and Optimer

10-04-2012

US health care giant Johnson & Johnson (NYSE: JNJ) said on Monday that Sherilyn (Sheri) McCoy, vice chairman…

AstraZenecaJohnson & JohnsonManagementOptimer PharmaceuticalsPharmaceutical

Watson confirms Lumigan and Latisse patent challenges; favorable Sanctura ruling

05-04-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories,…

AllerganGenericsGenito-urinaryLatisseLegalLumiganOphthalmicsPatentsSanctura XRWatson Pharmaceuticals

Array BioPharma presents encouraging Ph II selumetinib results in ovarian cancer

05-04-2012

Encouraging Phase II trial with selumetinib, a small-molecule MEK inhibitor developed by USA-based Array…

Array BioPharmaAstraZenecaOncologyPharmaceuticalResearchselumetinib

Head of NAFDAC advocates 200 billion naira lifeline for Nigerian pharma firms

05-04-2012

The Director-General of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC),…

FinancialGenericsPharmaceuticalRest of the World

BASF and Catalent join forces to address NME bioavailability challenges

04-04-2012

Privately-held USA-based Catalent Pharma Solutions has joined forces with German drug giant BASF (BAS:…

BASFCatalent PharmaGenericsPharmaceuticalResearch

AstraZeneca collaborates with Amgen on five MAbs

03-04-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and Amgen (Nasdaq: AMGN), the world's largest independent…

AmgenAnti-Arthritics/RheumaticsAstraZenecaBiotechnologybrodalumabInflammatory diseasesLicensingPharmaceutical

Poland breaking EU law by allowing unauthorized cheaper drugs

02-04-2012

Polish legislation authorizing the placing on the market of foreign medicinal products lacking authorization…

EuropeGenericsLegalMarkets & MarketingPharmaceuticalRegulation

Australian PBS prices slash in effect; clinical trial investment

02-04-2012

On April 1, 2012, in Australia, publicly funded generic medicines on the Pharmaceutical Benefits Scheme…

Asia-PacificGenericsPharmaceuticalPricingResearch

Lower drugs costs and insurance may help India achieve affordable medicines

01-04-2012

The next few years will spell considerable growth and change for the Indian health insurance industry,…

Asia-PacificGenericsHealthcarePharmaceuticalPricing

US Court upholds AstraZeneca Seroquel XR patent

30-03-2012

In some good news for the company, Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced last night…

Anchen PharmaceuticalsAstraZenecaGenericsMylan LaboratoriesNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XRTorrent Pharmaceuticals

Horizon Pharma sues Par for infringing Duexis patent

29-03-2012

Horizon Pharma (Nasdaq: HZNP) has filed a patent infringement lawsuit in the US District Court for the…

DuexisGenericsHorizon PharmaLegalNeurologicalNorth AmericaPar PharmaceuticalPatents

Sanofi and Bayer consider Russian expansion, product launches

28-03-2012

Two European drug majors - France-based Sanofi (Euronext: SAN) and German company Bayer (BAY: DE) have…

BayerEuropeGenericsInsulinMarkets & MarketingPharmaceuticalSanofi

STADA Arz sets up subsidiary in Australia

27-03-2012

German generics drugmaker STADA Arzneimittel (SAZ: GR) has established a subsidiary based in Sydney,…

Asia-PacificGenericsMarkets & MarketingSTADA Arzneimittel

1051 to 1075 of 1525 results

Company Spotlight

Fibrotech

Fibrotech

Back to top